Author:
Berg G.,Lindstedt G.,Suurküla M.,Jansson S.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference22 articles.
1. Reiners C., Farahati J. 131I therapy of thyroid cancer patients. Q. J. Nucl. Med. 1999, 43: 324–335.
2. Schlumberger M.J. Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 1998, 338: 297–306.
3. Goldman J.M., Line B.R., Aamondt R.L., Robbins J. Influence of triiodothyronine withdrawal time on 131-I uptake post-thyroidectomy for thyroid cancer. J. Clin. Endocrinol. Metab. 1980, 50: 734–739.
4. Dow K.H., Ferrell B.R., Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1997, 7: 613–619.
5. Jarzab B., Handkiewicz-Junak D., Gawkowska-Suwinska M. Recombinant human TSH in the diagnosis and treatment of disseminated differentiated thyroid cancer. Nucl. Med. Rev. 2000, 3: 83–88.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献